In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
about
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicansSynthesis and Biological Evaluation of Novel 2-Aminonicotinamide Derivatives as Antifungal Agents.Bst1 is required for Candida albicans infecting host via facilitating cell wall anchorage of Glycosylphosphatidyl inositol anchored proteins.A complex game of hide and seek: the search for new antifungalsOccurrence, presentation and treatment of candidemia.Early state research on antifungal natural products.The GPI anchor pathway: a promising antifungal target?Strategies in the discovery of novel antifungal scaffolds.The anti-Aspergillus drug pipeline: Is the glass half full or empty?Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.Aspergillus fumigatus Cap59-like protein A is involved in α1,3-mannosylation of GPI-anchors.In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.Antifungal resistance: current trends and future strategies to combat.The top three areas of basic research on Aspergillus fumigatus in 2011.In vitro and in vivo Evaluation of the Antifungal Activity of APX001A/APX001 Against Candida auris.New Horizons in Antifungal Therapy.In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.Targeting the GPI biosynthetic pathway.Significantly Improved Pharmacokinetics Enhances Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis
P2860
Q34923233-4FFE569F-7914-49B2-A7BE-25090153C8A3Q36245326-4FD54D2C-4BCB-413F-AC84-285B0B1BE2EEQ37314985-BA13FB70-A70B-4FA4-94D2-AB7C75BA5C02Q37344546-91DAC2C3-F022-4FC6-8FC7-29CDA6624F9EQ38061190-B0F276D1-9759-4D70-AA1B-8D5DA1E85ABFQ38194442-659612BD-9C34-402D-8AD8-8EBF57F3ADCAQ38832565-B2F0E9B0-7EB6-4F36-82AC-BD07198773CBQ38837363-3369FCA1-1519-4FF4-9BBA-CF290F77F5E4Q38937577-94E27806-4BEE-4CBE-9658-3DEF7ED777C5Q40327740-1AB561A0-FBC9-4C69-BE17-7F8977F74E1AQ40540301-1492A255-2102-4590-BA53-AFA97D90EEACQ40675286-EF392E00-1C61-4BB4-801B-EECFC4E5CC3FQ41632930-B3144222-ACF7-4801-BDAE-3F91F6AD7923Q44820840-B3D0D25E-659A-4E0A-9FEE-87974822A392Q47195606-B0912685-BE1A-4EF5-B78C-25D912042C43Q48149179-32FF363D-2E3D-40AF-883F-31FAC3CD04A1Q49598880-C7F09023-D03C-4D4E-84F9-0328F9D60E9DQ52683703-C39C7C6E-8238-431F-A898-95000D9E4281Q58701121-CD6D12E8-9F59-47B1-88B7-1D10EB8FE212
P2860
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vitro activity of a novel b ...... T broth microdilution methods.
@en
type
label
In vitro activity of a novel b ...... T broth microdilution methods.
@en
prefLabel
In vitro activity of a novel b ...... T broth microdilution methods.
@en
P2093
P2860
P356
P1476
In vitro activity of a novel b ...... T broth microdilution methods.
@en
P2093
Frederick Duncanson
Gary J Moet
Ronald N Jones
Shawn A Messer
P2860
P304
P356
10.1128/AAC.00570-11
P407
P577
2011-08-15T00:00:00Z